News
6/8/2007 - FDA "black box" warning request
June 8, 2007 Food and Drug Administration has asked that two controversial type 2 diabetes drugs carry a "black box" warning on the potentially heightened risk of congestive heart failure in some patients. FDA Commissioner Dr. Andrew von Eschenbach said the agency had asked that Avandia, and Actos, carry the more prominent warning because "despite existing warnings, these drugs were being prescribed to patients with significant heart failure."